2m 2m 2m 2m 2m 2m 2m
Climb Bio (CLYM)
NASDAQ
$9.69-$0.13 (-1.34%)
Price as of Oct 16, 2026 7:57 PM EDT- $564.0MMarket Cap
- 408.81%1-Year Change
- BiotechnologyIndustry
Climb Bio (CLYM)
$9.69-$0.13 (-1.34%)
CLYM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.82 | ||
Change | -$1.09 (-9.99%) | ||
Open | $10.89 | ||
High | $10.91 | ||
Low | $9.69 | ||
Previous Close | $10.91 | ||
Volume | 990,427 | ||
30-Day Average Volume | 1,334,926 | ||
1-Week Change | -10.73% | ||
1-Month Change | -30.40% | ||
1-Year Change | 408.81% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 57.4M | ||
Total Assets | $246.3M | ||
Market Cap | $564.0M | ||
Enterprise Value | $519.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.5M | ||
Free Cash Flow | -$10.5M | ||
EBIT | -$13.5M | ||
EBITDA | -$13.5M | ||
Net Working Capital | $180.7M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -55 | ||
PEG | -5 | ||
Price/Free Cash Flow | -53 | ||
Price/Operating Cash Flow | -53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue